Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Endometrial Neoplasms × Celecoxib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 16 Lung Neoplasms 12 Carcinoma, Non-Small-Cell Lung 12 Breast Neoplasms 12 Head and Neck Neoplasms 8 Rectal Neoplasms 7 Prostatic Neoplasms 7 Mouth Neoplasms 5 Glioblastoma 5 Esophageal Neoplasms 5 Colonic Neoplasms 5 Central Nervous System Neoplasms 5 Pancreatic Neoplasms 4 Neoplasm Metastasis 4 Gliosarcoma 4 Squamous Cell Carcinoma of Head and Neck 3 Sarcoma 3 Ovarian Neoplasms 3 Oropharyngeal Neoplasms 3 Neuroblastoma 3 Hypopharyngeal Neoplasms 3 Carcinoma 3 Brain Neoplasms 3 Tongue Neoplasms 2 Salivary Gland Neoplasms 2 Recurrence 2 Precancerous Conditions 2 Neoplasms 2 Nasopharyngeal Neoplasms 2 Medulloblastoma 2

Interventions

Paclitaxel 31 Carboplatin 24 pembrolizumab 17 Bevacizumab 15 Letrozole 13 Cisplatin 9 Megestrol Acetate 8 dostarlimab 7 olaparib 6 lenvatinib 6 abemaciclib 6 Metformin 6 durvalumab 5 Radiotherapy 5 Gemcitabine 5 Fluorouracil 5 Everolimus 5 Docetaxel 5 temsirolimus 4 rucaparib 4 niraparib 4 Specimen Handling 4 Oxaliplatin 4 Nivolumab 4 Medroxyprogesterone Acetate 4 Magnetic Resonance Spectroscopy 4 Fulvestrant 4 Doxorubicin 4 ridaforolimus 3 mirvetuximab soravtansine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03896113 2020-01-10

CELEBRIDO

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase 2 Unknown

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡